{"filing":{"accession_number":"0001437749-26-030831","cik":"0000925741","ticker":"BCDA","company_name":"BioCardia, Inc.","form":"8-K","filing_date":"2026-09-21","report_date":"2026-09-21","primary_document":"bcda20260921_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926030831/bcda20260921_8k.htm"},"events":[{"id":34027,"run_id":31324,"accession_number":"0001437749-26-030831","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"BioCardia disclosed receipt of a Nasdaq deficiency notice on August 19, 2026, for failure to maintain the $1.00 minimum bid price requirement, followed by notification on September 21, 2026, that the company regained compliance after 10 consecutive business days at or above $1.00. While the immediate delisting risk has been resolved, the disclosure centers on the company's listing status and the explicit caveat that \"there can be no assurance that the Company will be able to maintain compliance with the Minimum Bid Price Requirement in the future,\" which is material to investors assessing the registrant's continued trading status.","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":[{"id":37644,"accession_number":"0001437749-26-030831","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"BioCardia disclosed receipt of a Nasdaq deficiency notice on August 19, 2026, for failure to maintain the $1.00 minimum bid price requirement, followed by notification on September 21, 2026, that the company regained compliance after 10 consecutive business days at or above $1.00. While the immediate delisting risk has been resolved, the disclosure centers on the company's listing status and the explicit caveat that \"there can be no assurance that the Company will be able to maintain compliance with the Minimum Bid Price Requirement in the future,\" which is material to investors assessing the registrant's continued trading status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:32:03.541449+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37644,"accession_number":"0001437749-26-030831","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"BioCardia disclosed receipt of a Nasdaq deficiency notice on August 19, 2026, for failure to maintain the $1.00 minimum bid price requirement, followed by notification on September 21, 2026, that the company regained compliance after 10 consecutive business days at or above $1.00. While the immediate delisting risk has been resolved, the disclosure centers on the company's listing status and the explicit caveat that \"there can be no assurance that the Company will be able to maintain compliance with the Minimum Bid Price Requirement in the future,\" which is material to investors assessing the registrant's continued trading status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:32:03.541449+00:00","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-09-21"}]}